Media Alert: California Healthcare Institute, BayBio and PwC Present Live Media Webcast

January 26, 2011

SACRAMENTO, Calif., Jan. 26, 2011 /PRNewswire/ —

              Live Media Webcast to present findings of 2011 California
    EVENT:    Biomedical Industry Report

    WHEN:    Tuesday, Feb. 1, 2011

              9:00 a.m. - 9:45 a.m. PT /12:00 p.m. - 12:45 p.m. ET
    TIME:     presentation and Q&A

              --   David Gollaher, Ph.D., CEO, California Healthcare
    WHO:      Institute
              --   Tracy Lefteroff, National Life Sciences partner, PwC
             --    Gail Maderis, president and CEO, BayBio
              --   Paul Hastings, president and CEO, OncoMed
              Pharmaceuticals, Inc.

              To register for the webcast visit: http://
    HOW:      r.htm?e=281494&s=1&k=EB319C0A5E8D9FC9E6081CF046DFF9E8

             To listen by phone:  United States: (866) 804-3545
                                  International: +1 (703) 639-1326
                                  Conference ID: 1510773

    CONTACT: Caryn Brownell / Nicholas Parmelee
              The Hubbell Group, Inc. -- 781-878-8882
             cbrownell@hubbellgroup.com / nparmelee@hubbellgroup.com

(Logo: http://photos.prnewswire.com/prnh/20100917/NY66894LOGO )

The California Healthcare Institute (CHI), BayBio and PwC will present a live media webcast on Tuesday, Feb, 1 to unveil the 2011 California Biomedical Industry Report, the annual analysis of the state of the biomedical industry in California and its significance to biomedical clusters across the country. The presentation will provide an overview of:

  • Findings of a survey of CEOs from the state’s largest biomedical companies about their outlook for biomedical industry growth, threats to the industry, plans to expand or relocate operations inside/outside of California.
  • Employment trends across the state’s biomedical clusters.
  • Leading indicators of the industry’s health and economic impact: Wages, tax revenue, job creation, product pipeline, funding.
  • Implications of state and federal policies on the biomedical industry.
  • Best practices among states for attracting and retaining biomedical companies and talent.

The 20-minute presentation will be followed by Q&A with members of the media.

About the California Healthcare Institute

CHI represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI’s mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI’s website is www.chi.org. Follow us on Twitter @calhealthcare and Facebook.

About BayBio

BayBio is Northern California’s life science association, supporting the regional bioscience community through advocacy, enterprise support, and the enhancement of research collaboration. Its members include organizations engaged in, or supportive of, research, development and commercialization of life science technologies. Online at www.baybio.org.

About the PwC Network

PwC firms provide industry-focused assurance, tax and advisory services to enhance value for their clients. More than 161,000 people in 154 countries in firms across the PwC network share their thinking, experience and solutions to develop fresh perspectives and practical advice. See www.pwc.com for more information.

© 2011 PwC. All rights reserved. “PwC” and “PwC US” refer to PricewaterhouseCoopers LLP, a Delaware limited liability partnership, which is a member firm of PricewaterhouseCoopers International Limited, each member firm of which is a separate and independent legal entity.


Source: newswire

comments powered by Disqus